Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study
Diabetes Asia Journal · 30.01.2026 · 2 (4) · 63-69
DOI: 10.62996/daj.77052025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Asia Journal, online erschienen am 30.01.2026. Verfasst von Shweta Verma und 4 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
This study examines how Medical Nutrition Therapy (MNT) and Metformin help manage early gestational glucose intolerance during the 8th-10th weeks of pregnancy, especially when postprandial blood glucose (PPBG) is>110 mg/dL. The goal is to find out if these treatments can prevent gestational diabetes mellitus (GDM) and lower the risk of diabetes after pregnancy. Material and Methods A prospective cohort study was conducted at GSVM Medical Hospital in Kanpur, involving approximately 231 pregnant women at 8 to 10 weeks of gestation with pre-prandial blood glucose (PPBG) levels of at least 110 mg/dL. Participants were randomly assigned to either the MNT-Metformin group, receiving dosages ranging from 500 to 2500 mg, or the MNT-only group.
Results
At 2 to 3 days postpartum and at 6 weeks, the mean PPBG for the Metformin plus MNT group was 106.9 ± 5.24 mg/dL and 107.51 ± 10.67 mg/dL, respectively (P = 0.57). The mean HBA1c values were 4.84 ± 0.20 and 4.99 ± 0.37, respectively, with a P-value < 0.05.
Conclusion
Early detection and management of early gestational glucose intolerance (EGGI) with medical nutrition therapy (MNT) and Metformin can prevent progression to diabetes risk during postpartum screening. Keywords: EGGI Early gestational glucose intolerance, Gestational diabetes mellitus (GDM), PPBG Postprandial blood glucose, MNT Medical Nutrition Therapy, OGCT Oral Glucose challenge Test, DIPSI diabetes in Pregnancy Study Group India.
Zitieren
APA
Verma, S., Gupta, R., Gupta, N., Dwivedi, D., & Taneja, P. (2026). Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study. Diabetes Asia Journal, 2(4), 63-69. https://doi.org/10.62996/daj.77052025
Vancouver
Verma S, Gupta R, Gupta N, Dwivedi D, Taneja P. Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study. Diabetes Asia Journal. 2026;2(4):63-69. doi:10.62996/daj.77052025
BibTeX
@article{Verma2026,
author = {Verma, Shweta and Gupta, Renu and Gupta, Neena and Dwivedi, Divya and Taneja, Palak},
title = {Medical Nutrition Therapy & Metformin in Early Gestational Glucose Intolerance to Prevent Post-Partum Diabetes Risk in a hospital Prospective Study},
journal = {Diabetes Asia Journal},
year = {2026},
volume = {2},
number = {4},
pages = {63--69},
doi = {10.62996/daj.77052025}
}
EUVIMED